Targeting Myeloid Derived Suppressor Cells Reverts Immune Suppression and Sensitizes BRAF-Mutant Papillary Thyroid Cancer to MAPK Inhibitors

0
100
Scientists demonstrated that BRAFV600E promoted thyroid cancer development by increasing myeloid-derived suppressor cells penetrance.
[Nature Communications]
Full Article